Researchers and biopharmaceutical companies face significant hurdles in bringing life-changing therapies to the world. The journey from initial discovery to full-scale manufacturing is complex, requiring immense precision, scalability, and speed to meet the urgent needs of patients. Customers in this space, from academic researchers to global pharmaceutical giants, need a partner who can provide not just products, but integrated solutions and deep expertise to navigate these challenges. They require tools that enable them to work more efficiently, de-risk their processes, and accelerate the timeline from lab to clinic, ensuring that novel treatments for diseases like cancer, and other conditions, can be delivered safely and effectively.
Cytiva is dedicated to solving these critical challenges by advancing and accelerating therapeutics. As a trusted global life sciences leader with a rich heritage, we provide the essential technologies and services that our customers depend on. Our comprehensive portfolio, which includes renowned brands like ÄKTA, Amersham, HyClone, and Whatman, supports the entire workflow, from foundational biological research and process development to complete manufacturing solutions. We understand that our customers' work is vital, which is why we offer a breadth of solutions including instruments, consumables, and software that bring greater speed, efficiency, and capacity to their workflows. By partnering with our customers, we provide not just the tools, but also the collaborative support and expertise needed to overcome obstacles, scale production, and ultimately, transform human health by bringing innovative medicines to patients faster.